Your browser doesn't support javascript.
loading
Inhibitors of the GTPase KRASG12C in cancer: a patent review (2019-2021).
Xu, Qifu; Zhang, Guozhen; Liu, Qian; Li, Shunda; Zhang, Yingjie.
Afiliação
  • Xu Q; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Ji'nan, 250012, RP China.
  • Zhang G; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Ji'nan, 250012, RP China.
  • Liu Q; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Ji'nan, 250012, RP China.
  • Li S; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Ji'nan, 250012, RP China.
  • Zhang Y; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Ji'nan, 250012, RP China.
Expert Opin Ther Pat ; 32(5): 475-505, 2022 May.
Article em En | MEDLINE | ID: mdl-35062845

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Neoplasias Pulmonares Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Opin Ther Pat Assunto da revista: TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Neoplasias Pulmonares Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Opin Ther Pat Assunto da revista: TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article